"10.1371_journal.pone.0114268","plos one","2014-12-05T00:00:00Z","David S Wald; Jonathan P Bestwick; Lewis Raiman; Rebecca Brendell; Nicholas J Wald","Wolfson Institute of Preventive Medicine, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom","Conceived and designed the experiments: DSW NJW. Performed the experiments: DSW LR RB. Analyzed the data: DSW JPB NJW. Wrote the paper: DSW JPB LR RB NJW.","David Wald has read the journals policy and the authors of this manuscript have the following competing interests: Nicholas Wald jointly holds US, European and Canadian patents (EU1272220 priority date 10 April 2000) for a combination pill for the prevention of cardiovascular disease and together with David Wald is a shareholder in Polypill Ltd. Astra Zeneca part-funded the INTERACT trial. None of these disclosures alter the authors adherence to all PLOS ONE policies on data sharing and materials.","2014","12","David S Wald","DSW",5,TRUE,2,3,3,5,TRUE,TRUE,FALSE,0,NA,FALSE
